These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 34806426)
1. Novel effects of the gastrointestinal hormone secretin on cardiac metabolism and renal function. Laurila S; Rebelos E; Lahesmaa M; Sun L; Schnabl K; Peltomaa TM; Klén R; U-Din M; Honka MJ; Eskola O; Kirjavainen AK; Nummenmaa L; Klingenspor M; Virtanen KA; Nuutila P Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E54-E62. PubMed ID: 34806426 [TBL] [Abstract][Full Text] [Related]
5. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography. Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179 [TBL] [Abstract][Full Text] [Related]
6. Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemia. Gejl M; Lerche S; Mengel A; Møller N; Bibby BM; Smidt K; Brock B; Søndergaard H; Bøtker HE; Gjedde A; Holst JJ; Hansen SB; Rungby J PLoS One; 2014; 9(1):e83758. PubMed ID: 24400077 [TBL] [Abstract][Full Text] [Related]
7. Secretin activates brown fat and induces satiation. Laurila S; Sun L; Lahesmaa M; Schnabl K; Laitinen K; Klén R; Li Y; Balaz M; Wolfrum C; Steiger K; Niemi T; Taittonen M; U-Din M; Välikangas T; Elo LL; Eskola O; Kirjavainen AK; Nummenmaa L; Virtanen KA; Klingenspor M; Nuutila P Nat Metab; 2021 Jun; 3(6):798-809. PubMed ID: 34158656 [TBL] [Abstract][Full Text] [Related]
8. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. Rechavia E; de Silva R; Kushwaha SS; Rhodes CG; Araujo LI; Jones T; Maseri A; Yacoub MH J Am Coll Cardiol; 1997 Aug; 30(2):533-8. PubMed ID: 9247529 [TBL] [Abstract][Full Text] [Related]
9. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet. Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066 [TBL] [Abstract][Full Text] [Related]
11. Associations of physiologic myocardial Kang JY; Lee MY; Kim YH Ann Nucl Med; 2021 Feb; 35(2):195-202. PubMed ID: 33387280 [TBL] [Abstract][Full Text] [Related]
12. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study. Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634 [TBL] [Abstract][Full Text] [Related]
13. 18F-FDG uptake and clearance in patients with compromised renal function. Akers SR; Werner TJ; Rubello D; Alavi A; Cheng G Nucl Med Commun; 2016 Aug; 37(8):825-32. PubMed ID: 27058366 [TBL] [Abstract][Full Text] [Related]
14. The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-D-glucose. Ding HJ; Shiau YC; Wang JJ; Ho ST; Kao A Nucl Med Commun; 2002 Oct; 23(10):961-5. PubMed ID: 12352594 [TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis. Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232 [TBL] [Abstract][Full Text] [Related]
16. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124 [TBL] [Abstract][Full Text] [Related]
18. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981 [TBL] [Abstract][Full Text] [Related]
19. Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart. Mongillo M; John AS; Leccisotti L; Pennell DJ; Camici PG Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1172-7. PubMed ID: 17294189 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]